| 注册
首页|期刊导航|中国临床药理学杂志|维生素D联合布地奈德治疗儿童肺炎支原体肺炎的临床研究

维生素D联合布地奈德治疗儿童肺炎支原体肺炎的临床研究

张敏 梁立东 顾洁 张中林

中国临床药理学杂志2024,Vol.40Issue(7):939-943,5.
中国临床药理学杂志2024,Vol.40Issue(7):939-943,5.DOI:10.13699/j.cnki.1001-6821.2024.07.001

维生素D联合布地奈德治疗儿童肺炎支原体肺炎的临床研究

Clinical trial of vitamin D combined with budesonide in the treatment of Mycoplasma pneumoniae pneumonia in children

张敏 1梁立东 1顾洁 1张中林2

作者信息

  • 1. 银川市妇幼保健院儿科,宁夏回族自治区银川 750004
  • 2. 银川市第二人民医院 儿科,宁夏回族自治区 银川 750011
  • 折叠

摘要

Abstract

Objective To analyze the clinical effect of vitamin D combined with budesonide suspension in the treatment of Mycoplasma pneumoniae pneumonia in children and the influence on peripheral blood T lymphocyte subsets and serum interleukin-17(IL-17)and hypersensitive C-reactive protein(hs-CRP).Methods Children with severe Mycoplasma pneumoniae pneumonia were classified into control group and treatment group by adopting the random number table method.The control group was treated with budesonide aerosol inhalation therapy(1 mL for ≤7 years old,2 mL for>7 years old,twice a day for 2 weeks),and the treatment group was additionally given oral administration of vitamin D(400 U,once a day for 2 weeks).The clinical effect,disappearance times of clinical symptoms and signs,peripheral blood T lymphocyte subsets,serum IL-17,hs-CRP and 25-hydroxy vitamin D(25(OH)D)and occurrence of adverse drug reactions were compared between both groups of children.Results Eleven cases dropped out during treatment,and finally forty cases were included in treatment group and control group respectively.After treatment,the total effective rates in treatment group and control group were 97.50%(39 cases/40 cases)and 82.50%(33 cases/40 cases);the cough disappearance times were(5.14±1.08)and(6.87±1.24)d;the rale disappearance times were(6.69±1.21)and(8.52±1.29)d;CD3+levels were(68.03±5.68)%and(64.61±6.84)%;CD4+levels were(44.26±5.83)%and(39.94±5.01)%;CD4+/CD8+levels were 1.37±0.33 and 1.24±0.21;serum IL-17 levels were(22.84±4.13)and(39.21±8.68)pg·mL-1;hs-CRP levels were(3.25±0.72)and(6.07±1.11)mg·L-1;25(OH)D levels were(36.42±6.86)and(24.25±6.03)ng·mL-1,respectively(all P<0.05).During the treatment period,the adverse drug reactions of the two groups were mainly diarrhea,vomiting,abdominal discomfort and throat irritation.The total incidence of adverse drug reactions in treatment group and control group was 22.50%and 17.50%,respectively,and there was no statistically significant difference(P>0.05).Conclusion Vitamin D combined with budesonide suspension has a significant clinical effect in the treatment of Mycoplasma pneumoniae pneumonia in children,and it can effectively relieve symptoms,regulate the levels of T lymphocyte subsets,and reduce the levels of serum IL-17 and hs-CRP,with good safety.

关键词

维生素D/布地奈德混悬液/儿童/肺炎支原体肺炎/T淋巴细胞亚群

Key words

vitamin D/budesonide suspension/children/Mycoplasma pneumoniae pneumonia/T lymphocyte subsets

分类

医药卫生

引用本文复制引用

张敏,梁立东,顾洁,张中林..维生素D联合布地奈德治疗儿童肺炎支原体肺炎的临床研究[J].中国临床药理学杂志,2024,40(7):939-943,5.

中国临床药理学杂志

OA北大核心CSTPCD

1001-6821

访问量0
|
下载量0
段落导航相关论文